An interventional study of HIIT and LIGT in Stroke, sponsored by Hôpital Léon Bérard. Active, not recruiting at 1 site in France. Open to participants aged 18 Years and older. Per ClinicalTrials.gov, last updated 2025-12-31.
Sponsored by Hôpital Léon Bérard · Not applicable, Interventional, and Prevention
Objective. To assess the effect of innovative "High-Intensity Interval Training" (HIIT) on Heart Rate Variability, a strong biomarker of positive outcome after stroke.
Design. A randomized controlled study with blinded assessment of the main criteria.
Population. NIHSS\<20 post-stroke patients, hospitalized in secondary care stroke-units within the first 3 months (sub-acute phase).
Selection. Eligibility test on a semi-recumbent cycloergometer Intervention. In addition to a standard neurorehabilitation program (3±1 sessions daily, including cognitive and occupational therapy, physiotherapy with strengthening-stretching exercises), the aerobic group will benefit from a HIIT procedure (HIIT group) with a semi-recumbent cycloergometer, for 6 weeks representing 16 sessions; while the non-aerobic group will undertake a "Low-Intensity Group-Gymnastic Training" (Control or LIGT Group) (=segmental strengthening-stretching and proprioceptive exercises mainly), with the same training volume and frequency for both groups.
Main outcome measure. Standard Deviation of Normal-to-Normal RR intervals (SDNN) from 24h Holter-ECG recordings at W4, W8 and M6.
Modifications in patients' medical management are expected, as generalization of AT in moderate to severe stroke patients at the sub-acute phase, with "Low volume HIIT" and simple devices.
A randomized controlled 2-arms parallel study, comparing HRV in two groups of stroke patients.
Post-acute stroke patients hospitalized in rehabilitation stroke¬-units, within secondary care hospitals, are screened for eligibility.
Inclusion criteria:
Non-inclusion criteria:
In addition, either aerobic training (HIIT) or non-aerobic training (Control Group-CG by Low Intensity Group Training-LIGT).
The intervention-group (HIIT Group) will realize a 6-weeks Aerobic Training as follows:
Among the FITT principle:
Intensity: long-HIIT: 4 to 5 four-minutes intervals at Pvt1(+/- 2 steps) interspersed with two-minutes interval at 50% Pvt1=(4-5 x (4':2')/(Pvt1 :50%Pvt1))
In the CG group, HIIT will be replaced by "LIGT" sessions, as follows:
Among the FITT principle:
Type: Static and Segmental strengthening and stretching mainly
Measures taken to reduce bias:
-Patients' spontaneous physical activity will be monitored via two sets of four-day measurements, including weekends, using an Actigraph device worn on a belt.
Patients who would have been in the control-group will be proposed to enter in an out-patient (day-hospital) HIIT program.
Novelty
To allow generalization of conclusions:
(Indeed, most of non-ambulatory participants (82% ) in RCTs benefited from AT through assistive walking devices, using Weight Bearing Support Treadmill, which are difficult to set up (accessibility, personnel and equipment costs…)).
7,286 studies on the registry are indexed under Stroke; 2,007 are open to participants now.
This study's planned enrollment of 50 is close to the median of 50 across 5,369 interventional studies indexed under Stroke.
Browse Stroke studies →Hôpital Léon Bérard is the lead sponsor of 5 studies on the registry; none are open to participants now.
Counted across the registry records on this site, refreshed daily.
Exclusion Criteria:
HIIT 16 sessions of 12 to 30 minutes, over 6 weeks.
Other: HIIT
LIGT 16 sessions of 12 to 30 minutes, over 6 weeks.
Other: LIGT
High Intensity Interval Training On semi-recumbent ergocyclometer, after a symptom-limited graded exercise Test
Low Intensity Group Training Group gymnastics, mainly with short static stretching/strengthening tasks.
SDNN
Standard Deviation of all Normal-to-Normal RR intervals, recorded with a 24h-Holter ECG.
Time frame: Week 1, Week 8, Month 6
HRV
Others data from the Heart Rate Variability analysis
Time frame: Week 1, Week 8, Month 6
Dose Ratio
Delivered/Planned ratio, as Internal Acceptability
Time frame: Week 2 to Week 7
VO2peak
VO2peak gain between the first and second CPET will be compared
Time frame: Week1 Vs Week 8
Plan to share: Yes — Data will be available upon reasonable request. De-identified participant data will be available, from all types, for corresponding relevant Editor, or Meta-analyses need. Other detailed request will be examined. Via controlled access repositories
Supporting information: Study protocol, Sap, Icf, Csr, Analytic code
This study is active, not recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hôpital Léon Bérard